Nasus Pharma Ltd.
0.1M
$22.57M
-48.79
$-0.17
No price alerts set. Add an alert to get notified!
-48.79
0.00
$-0.17
-
0.00%
0.00%
Compare TSM with similar companies in the sector
| Company | Price | Change % | P/E | Market Cap | D/E |
|---|---|---|---|---|---|
|
ACET
Adicet Bio, Inc.
|
$6.93 | -3.62% | -0.41 | $66.53M | 0.09 |
|
ACRV
Acrivon Therapeutics, Inc. Common Stock
|
$1.64 | -1.20% | -0.77 | $51.75M | 0.02 |
|
ADAG
Adagene Inc.
|
$3.94 | 0.77% | -3.86 | $148.56M | 0.18 |
|
CRVO
CervoMed Inc.
|
$4.24 | -6.40% | -1.45 | $39.23M | 0.00 |
|
FBIO
Fortress Biotech, Inc.
|
$3.16 | 1.28% | 21.59 | $98.08M | 1.22 |
|
GANX
Gain Therapeutics, Inc.
|
$1.95 | -25.57% | -3.52 | $75.00M | 0.10 |
|
LITS
Lite Strategy, Inc.
|
$1.18 | -2.48% | -0.20 | $43.39M | 0.00 |
|
NTRB
Nutriband Inc.
|
$3.93 | 0.51% | -3.71 | $47.85M | 0.03 |
|
TCRX
TScan Therapeutics, Inc.
|
$1.07 | -1.83% | -1.07 | $60.88M | 0.76 |
|
XBIT
XBiotech Inc.
|
$2.25 | 0.00 | -1.51 | $68.60M | 0.00 |
* Peer stocks are selected based on market capitalization and sector
$9.99
$2.60
$0.00
0.00%
Nasus Pharma is a clinical-stage specialty pharmaceutical company focused primarily on the development of intranasal drugs to treat emergency medical conditions such as severe allergies, anaphylaxis, and opioid overdose. Their lead products include NS002, an intranasal powder epinephrine nasal spray for type 1 severe allergies and anaphylaxis, and NS001, an intranasal naloxone powder spray for opioid overdose. They use a powder-based intranasal technology that offers rapid drug absorption.
